Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity
- 1 March 2000
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (6) , 547-549
- https://doi.org/10.1016/s0960-894x(00)00046-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]Journal of Biological Chemistry, 1999
- Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial TherapyNew England Journal of Medicine, 1998
- Solubilization, Partial Purification, and Affinity Labeling of the Membrane-Bound Isoprenylated Protein EndoproteaseBiochemistry, 1996
- Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesScience, 1995
- Sensitivity of Primary Clonogenic Blasts from Acute Lymphoblastic Leukemia Patients to an Activated Cyclophosphamide, viz., MafosfamideLeukemia & Lymphoma, 1994
- Pretransplantation Burden of Leukemic Progenitor Cells as a Predictor of Relapse after Bone Marrow Transplantation for Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1993
- Prenylated proteins. A convenient synthesis of farnesyl cysteinyl thioethersJournal of the American Chemical Society, 1991